RecalledThisWeek Search
Medium risk Drugs & MedicationsClass II

Major Pharmaceuticals Levothyroxine 75mcg Recall

Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 10 Tablets (10 x 1) unit dose blisters per carton, Rx only, Packaged and Distributed b

Updated July 13, 2026

Major Pharmaceuticals' Levothyroxine Sodium Tablets, USP 75 mcg, have been found to be subpotent, meaning they contain less active ingredient than stated. Patients taking this medication may not receive the full therapeutic dose needed to manage their thyroid condition.

Is the Major Pharmaceuticals recalled? Yes. This product was recalled by FDA on July 13, 2026. Details below.

What is recalled

Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), packaged in 10 x 1 unit dose blisters per carton, Rx only. Packaged and distributed by Major Pharmaceuticals, Indianapolis, IN 46268. Distributed by Cardinal Health, Dublin, OH 43017. NDC Bag: 55154-3560-0; NDC Blister: 0904-6951-61.

Am I affected

You're affected if you have a prescription for Levothyroxine Sodium Tablets 75 mcg in unit dose blisters from Major Pharmaceuticals with NDC Bag 55154-3560-0 or NDC Blister 0904-6951-61. Check the label on your medication bottle or blister pack for these numbers.

What to do right now

Stop taking this medication and contact your pharmacist or doctor right away. Do not discontinue thyroid treatment on your own; your healthcare provider will advise you on what to do next, which may include a replacement supply or dosage adjustment.

The hazard

Subpotent Drug

Brands affected

Major Pharmaceuticals
Source
FDA
Category
Drugs & Medications
Recall ID
fda-D-0709-2026
Classification
Class II
Recalled
July 13, 2026
Read the official notice

Get free recall alerts

New Drugs & Medications recalls, the moment they post.

Free forever. Unsubscribe anytime. We never sell your data.

More Drugs & Medications recalls